Skip to main content
. 2017 Apr 20;123(1):55–61. doi: 10.1152/japplphysiol.00205.2017

Table 1.

Sample characteristics

Control (n = 29) Inotrope-Exposed (n = 11) P Value
Patient factors
Gestational age, mean (SD) wk 25.4 (1.5) 24.8 (1.8) 0.26
Birth weight, mean (SD) g 808 (197) 745 (250) 0.17
IUGR status, n (%) 1 (3) 0 (0) 1.00
Male sex, n (%) 15 (52) 4 (36) 0.48
Race/ethnicity
    Asian, n (%) 1 (3) 1 (9) 0.28
    Black, n (%) 10 (35) 4 (37)
    Hispanic, n (%) 0 (0) 1 (9)
    White, n (%) 18 (62) 5 (45)
Perinatal factors
Vaginal delivery, n (%) 8 (28) 1 (9) 0.39
Antenatal MgSO4 exposure, n (%) 19 (66) 8 (72) 1.00
Antenatal steroid exposure
    Any exposure, n (%) 25 (86) 9 (82) 1.00
    Complete course, n (%) 17 (59) 9 (82) 0.27
Preeclampsia, n (%) 7 (24) 3 (27) 1.00
Chorioamnionitis§, n (%) 4 (14) 3 (27) 0.37
Cord pH, mean (SD) 7.30 (0.09) 7.34 (0.07) 0.53
Apgar score 5 min, median (range) 6 (1–9) 5 (2–9) 0.24
Clinical factors
Initial MABP, mean (SD) mmHg 28.6 (6.3) 23.9 (3.9) 0.02*
CRIB II score, median (range) 12 (8–17) 14.5 (8–17) 0.02*
Culture-positive sepsis, n (%) 0 (0) 2 (18) 0.07
Intraventricular hemorrhage
    Any grade, n (%) 8 (28) 8 (72) 0.01*
    Grade III/IV, n (%) 5 (17) 6 (55) 0.04*
Died, n (%) 2 (7) 4 (36) 0.04*

IUGR, intrauterine growth restriction; MABP, mean arterial blood pressure.

*

Statistical significance at P < 0.05.

Birth weight <10th centile;

2 doses of β-methasone over a 48-h period;

§

based on histopathological diagnosis.